The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gender disparities in National Institute of Health funding for hematologic malignancies, hematopoietic stem cell transplantation, and cellular therapeutics.
 
Raheel Sufian Siddiqui
No Relationships to Disclose
 
Moazzam Shahzad
No Relationships to Disclose
 
Mahrukh Majeed
No Relationships to Disclose
 
Ali Hussain
No Relationships to Disclose
 
Faryal Murtaza
No Relationships to Disclose
 
Farhan Khalid
No Relationships to Disclose
 
Ayesha Habib
No Relationships to Disclose
 
Zobia Aijaz
No Relationships to Disclose
 
Syeda Sadia Bukhari
No Relationships to Disclose
 
Iqra Anwar
No Relationships to Disclose
 
Sehar Altaf
No Relationships to Disclose
 
Faiz Anwer
Honoraria - Incyte; Seagen; Seagen
Consulting or Advisory Role - Incyte; Seagen
Speakers' Bureau - Incyte
Research Funding - Abbvie; Acetylon Pharmaceuticals; Astellas Pharma; Celgene; Millennium
Travel, Accommodations, Expenses - Incyte; Seagen
 
Sibgha Gull Chaudhary
No Relationships to Disclose
 
Ramesh Balusu
No Relationships to Disclose
 
Nausheen Ahmed
No Relationships to Disclose
 
Siddhartha Ganguly
Honoraria - Astellas Pharma; Kite, a Gilead company; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Sanofi/Aventis
Speakers' Bureau - Kite, a Gilead company; Seagen
Research Funding - Daiichi Sankyo (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company; Seagen
 
Sunil H. Abhyankar
Consulting or Advisory Role - Incyte
Speakers' Bureau - Therakos
Research Funding - Incyte
 
Joseph McGuirk
Honoraria - AlloVir; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics
Consulting or Advisory Role - Allovir; EcoR1 Capital; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics
Speakers' Bureau - Kite/Gilead
Research Funding - AlloVir (Inst); Astellas Pharma (Inst); Bellicum Pharmaceuticals (Inst); Fresenius Biotech (Inst); Gamida Cell (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Novartis (Inst); Pluristem Therapeutics (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Faisal Khosa
No Relationships to Disclose
 
Muhammad Umair Mushtaq
No Relationships to Disclose